Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Nuklearmedizin
    April 2024
  1. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    >> Share

  2. BOCK F, Frerker B, Schubert L, Rennau H, et al
    Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.
    Nuklearmedizin. 2024 Apr 5. doi: 10.1055/a-2284-0593.
    >> Share

  3. SAEED S, Dimopoulos I, Begum N, Kroger JR, et al
    [Not Available].
    Nuklearmedizin. 2024;63:78-80.
    >> Share

  4. WERNER R, Haug A, Buske C, Heidegger S, et al
    CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
    Nuklearmedizin. 2024;63:57-61.
    >> Share

    March 2024
  5. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 25. doi: 10.1055/a-2286-9571.
    >> Share

  6. USLU H, Sahin D, Tatoglu MT, Ibisoglu E, et al
    Growing Teratoma Syndrome Revealed By F-18 FDG PET/CT.
    Nuklearmedizin. 2024 Mar 14. doi: 10.1055/a-2273-2350.
    >> Share

  7. GACULA SIG, Kunte SC, Unterrainer LM, Rubenthaler J, et al
    Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.
    Nuklearmedizin. 2024 Mar 11. doi: 10.1055/a-2273-2447.
    >> Share

  8. LIU Y, Tang W, Huang Z
    Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
    >> Share

    February 2024
  9. CHEN M, Liu Y
    Correction: 18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2265-4049.
    >> Share

  10. AYDAR S, Knobl H, Burchert W, Lindner O, et al
    Diagnostic accuracy of artificial intelligence-enabled vectorcardiography versus myocardial perfusion SPECT in patients with suspected or known coronary heart disease.
    Nuklearmedizin. 2024 Feb 20. doi: 10.1055/a-2263-2322.
    >> Share

  11. CHEN M, Liu Y
    18F-FDG PET/CT images of adult pulmonary blastoma: a case report.
    Nuklearmedizin. 2024 Feb 7. doi: 10.1055/a-2237-8775.
    >> Share

  12. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    >> Share

  13. FISCHER M, Schneider-Eicke J
    Nonosseous bone seeking tracer focal uptake in the conventional scintigraphy.
    Nuklearmedizin. 2024;63:45-47.
    >> Share

  14. DIETLEIN M, Grunwald F, Schmidt M, Kreissl MC, et al
    [Guideline for Radioiodine Therapy for Benign Thyroid Diseases (6/2022 - AWMF No. 031-003)].
    Nuklearmedizin. 2024;63:8-20.
    >> Share

    January 2024
  15. FREUDENBERG R, Kastner D, Kotzerke J, Brogsitter C, et al
    [Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine].
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2237-8639.
    >> Share

  16. MAMAN A
    Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.
    Nuklearmedizin. 2024 Jan 23. doi: 10.1055/a-2238-4186.
    >> Share

  17. NOURBAKHSH S, Salehi Y, Farzanehfar S, Ghaletaki R, et al
    FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2185-7746.
    >> Share

  18. ARSLANTAS E, Aycicek A, Esen Akkas B, Tahtakesen Gucer TN, et al
    The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9441.
    >> Share

  19. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    >> Share

  20. SANTO G, Di Santo G, Zelger B, Virgolini I, et al
    Incidental Finding of a Pancreatic Adenocarcinoma on [68Ga]Ga-PSMA-11 PET/CT in a mCRPC patient under [177Lu]Lu-PSMA-617 Radioligand Therapy.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2221-3220.
    >> Share

    December 2023
  21. SERFLING SE, Buck A, Rowe SP, Higuchi T, et al
    Red Bull PET/CT.
    Nuklearmedizin. 2023 Dec 22. doi: 10.1055/a-2195-0138.
    >> Share

  22. ROGASCH JMM, Shi K, Kersting D, Seifert R, et al
    Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
    Nuklearmedizin. 2023;62:361-369.
    >> Share

  23. WENDLER T, Kreissl MC, Schemmer B, Rogasch JMM, et al
    Artificial Intelligence-powered automatic volume calculation in medical images - available tools, performance and challenges for nuclear medicine.
    Nuklearmedizin. 2023;62:343-353.
    >> Share

  24. HELLWIG D, Hellwig NC, Boehner S, Fuchs T, et al
    Artificial Intelligence and Deep Learning for Advancing PET Image Reconstruction: State-of-the-Art and Future Directions.
    Nuklearmedizin. 2023;62:334-342.
    >> Share

  25. MIEDERER I, Rogasch JMM, Wendler T
    AI in Nuclear Medicine - a review of the current situation.
    Nuklearmedizin. 2023;62:332-333.
    >> Share

    November 2023
  26. LOHMANN P, Bundschuh RA, Miederer I, Mottaghy FM, et al
    Clinical Applications of Radiomics in Nuclear Medicine.
    Nuklearmedizin. 2023 Nov 7. doi: 10.1055/a-2191-3271.
    >> Share

    October 2023
  27. FUCHS T, Kaiser L, Muller D, Papp L, et al
    Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
    Nuklearmedizin. 2023 Oct 31. doi: 10.1055/a-2187-5701.
    >> Share

  28. RASSEK P, Bobe S, Kies P, Roll W, et al
    The value of core needle biopsy in the diagnostic workup of a [18F]FDG-PET positive thyroid metastasis from colorectal cancer.
    Nuklearmedizin. 2023 Oct 23. doi: 10.1055/a-2178-6908.
    >> Share

  29. BROSCH-LENZ JF, Delker A, Schmidt F, Tran-Gia J, et al
    On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Nuklearmedizin. 2023 Oct 12. doi: 10.1055/a-2179-6872.
    >> Share

  30. MOON H, Ku EJ, Kim C
    Ectopic Thyroid Tissue in the Uterus Identified by Iodine-131 SPECT/CT.
    Nuklearmedizin. 2023;62:294-295.
    >> Share

  31. KUSTNER T, Hepp T, Seith F
    Multiparametric Oncologic Hybrid Imaging: Machine Learning Challenges and Opportunities.
    Nuklearmedizin. 2023;62:306-313.
    >> Share

    September 2023
  32. DEININGER K, Raacke JN, Yousefzadeh-Nowshahr E, Kropf-Sanchen C, et al
    Combined morphologic-metabolic biomarkers from [18F]FDG-PET/CT stratify prognostic groups in low-risk NSCLC.
    Nuklearmedizin. 2023 Sep 11. doi: 10.1055/a-2150-4130.
    >> Share

  33. MIEDERER I, Rogasch JMM, Fischer R, Fuchs T, et al
    The Medical Informatics Initiative and the Network University Medicine - Perspectives for Nuclear Medicine.
    Nuklearmedizin. 2023 Sep 8. doi: 10.1055/a-2067-7642.
    >> Share

    August 2023
  34. RASSEK P, Schafers M, Rahbar K, Backhaus P, et al
    [18F]-PSMA-1007-PET for evaluation of kidney function.
    Nuklearmedizin. 2023 Aug 18. doi: 10.1055/a-2127-7880.
    >> Share

  35. KAPLAN I, Kepenek F, Guzel Y, Can C, et al
    The Role of 68Ga FAPI-04 and 18F-FDG PET/CT in Detecting Liver Metastases in Different Types of Cancer.
    Nuklearmedizin. 2023 Aug 18. doi: 10.1055/a-2127-7699.
    >> Share

  36. FROHLICH M, Schmalzing M, Buck A, Bley TA, et al
    PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2023;62:229-234.
    >> Share

    June 2023
  37. LINDNER O, Schaefer WM, Silber S, Rischpler C, et al
    Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany: Results of the 9th Survey.
    Nuklearmedizin. 2023 Jun 2. doi: 10.1055/a-2084-7454.
    >> Share

  38. LAPA C, Rischpler C, Bundschuh RA, Dierks A, et al
    Value of [18F]FDG PET/CT in diagnosis and management of spondylodiscitis.
    Nuklearmedizin. 2023;62:192-199.
    >> Share

  39. CEGLA P, Wojewodzka-Mirocha M, Chalewska W, Dedecjus M, et al
    [68Ga]Ga-PSMA-11 uptake in planepitheliale lung cancer: a pitfall in prostate cancer imaging.
    Nuklearmedizin. 2023;62:220-221.
    >> Share

    April 2023
  40. ZIPPEL C, Antke C, Mori Y, Sombetzki A, et al
    [Breakeven Analysis for Imaging Devices: Basic Introduction with Presentation of a User-Friendly Tool for in-clinic Calculation Using PET/CT as an Example].
    Nuklearmedizin. 2023 Apr 5. doi: 10.1055/a-2036-7694.
    >> Share

  41. EILSBERGER F, Lapa C, Klasner B, Schafers MA, et al
    [Hand in hand - the future of SPECT and PET imaging].
    Nuklearmedizin. 2023;62:52-53.
    >> Share

  42. KARIMIPOURFARD M, Sina S, Khodadai Shoshtari F, Alavi M, et al
    Correction: Synthesis of Prospective Multiple Time Points F-18 FDG PET Images from a Single Scan Using a Supervised Generative Adversarial Network.
    Nuklearmedizin. 2023;62:e1.
    >> Share

    March 2023
  43. KARIMIPOURFARD M, Sina S, Khodadai Shoshtari F, Alavi M, et al
    Synthesis of Prospective Multiple Time Points F-18 FDG PET Images from a Single Scan Using a Supervised Generative Adversarial Network.
    Nuklearmedizin. 2023 Mar 6. doi: 10.1055/a-2026-0784.
    >> Share

  44. LIU Y, Tang W, Huang Z
    99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma.
    Nuklearmedizin. 2023 Mar 6. doi: 10.1055/a-2036-7741.
    >> Share

    February 2023
  45. KERTESZ H, Traub-Weidinger T, Cal-Gonzalez J, Rausch I, et al
    Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy.
    Nuklearmedizin. 2023 Feb 20. doi: 10.1055/a-2015-7785.
    >> Share

  46. LIU H, Yang X, You Z, Hu Z, et al
    Role of 68Ga-FAPI-04 PET/CT in the Initial Staging of Esophageal Cancer.
    Nuklearmedizin. 2023;62:38-44.
    >> Share

  47. ARSLANTAS E, Aycicek A, Akici F, Ozkara S, et al
    Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
    Nuklearmedizin. 2023;62:20-26.
    >> Share

  48. AFSHAR-OROMIEH A, Eiber M, Fendler W, Schmidt M, et al
    [Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT].
    Nuklearmedizin. 2023;62:5-19.
    >> Share

  49. HAPPEL C, Groner D, Kranert WT, Grunwald F, et al
    Evaluation of activity kinetics in breast milk and calculation of the resulting effective radiation dose after 99mTc-MIBI scintigraphy of a breastfeeding women.
    Nuklearmedizin. 2023;62:45-46.
    >> Share

    January 2023
  50. SAHIN YA, Eilsberger F, Einspanner E, Kunz J, et al
    [Is there an unmet need to establish a young talent section "Young DGN" within the German Society of Nuclear Medicine (DGN)? - Results of a 2021/2022 web-based survey among German Nuclear Medicine professionals].
    Nuklearmedizin. 2023 Jan 27. doi: 10.1055/a-1984-8116.
    >> Share

  51. KNAPPE LM, Verburg FA, Giovanella L, Luster M, et al
    Diagnostic value of FDG-PET/CT in the diagnostic work-up of inflammation of unknown origin.
    Nuklearmedizin. 2023 Jan 9. doi: 10.1055/a-1976-1765.
    >> Share

  52. NAZERANI-ZEMANN T, Stanzel S, Gstettner C, Aigner RM, et al
    F18-FDG PET/CT in a patient with Antisynthetase Syndrome.
    Nuklearmedizin. 2023 Jan 4. doi: 10.1055/a-1996-0157.
    >> Share

    December 2022
  53. NEUBERGER M, Dropmann JA, Kleespies A, Fuerst H, et al
    Determinants and clinical significance of negative scintigraphic findings in primary hyperparathyroidism: a retrospective observational study.
    Nuklearmedizin. 2022;61:440-448.
    >> Share

    October 2022
  54. SCHEER C, Juptner M, Maier T, Lutzen U, et al
    Unusual accumulation of 177Lu-DOTATATE at the injection site of a COVID-19 vaccination.
    Nuklearmedizin. 2022;61:410-413.
    >> Share

  55. SCHENKE SA, Kreissl MC, Grunert M, Hach A, et al
    Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany.
    Nuklearmedizin. 2022;61:376-384.
    >> Share

    August 2022
  56. GUGGENBERGER KV, Vogt ML, Rowe SP, Higuchi T, et al
    Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis.
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1830-7767.
    >> Share

  57. FREUDENBERG LS, Freudenberg BJ, Klett R, Herrmann K, et al
    [Nuclear Medicine Physicians: A threatened species?]
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1907-4122.
    >> Share

  58. AGULOGLU N, Aksu A, Akyol M, Katgi N, et al
    IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1868-4918.
    >> Share

  59. KREBOLD AK, Schaller T, Appenzeller M, Schwaiblmair M, et al
    [18F]FDG PET/CT guided biopsy confirms diagnosis of granulomatosis with polyangiitis.
    Nuklearmedizin. 2022 Aug 17. doi: 10.1055/a-1907-4248.
    >> Share

  60. EILSBERGER F, Luster M, Librizzi D, Rodepeter F, et al
    Medullary Thyroid Carcinoma presenting as an Incidentaloma on Gallium-68-PSMA-PET/CT - Systematic Literature Review and Case Report.
    Nuklearmedizin. 2022 Aug 11. doi: 10.1055/a-1896-0106.
    >> Share

  61. KUGLER A, Kuwert T, Ritt P, Grings A, et al
    Influence of CT metal artifact reduction on SPECT/CT quantification of bone scintigraphy - Retrospective study for selected types of metal implants.
    Nuklearmedizin. 2022 Aug 9. doi: 10.1055/a-1883-9281.
    >> Share

  62. ABOUZIAN S, Camacho V, Sabate A, Stefaneli P, et al
    Audiovisual intervention alleviates anxiety of patients during PET/CT imaging.
    Nuklearmedizin. 2022;61:301-307.
    >> Share

    July 2022
  63. BEINDORFF N, Papadopoulos N, Hoffmann S, Mohan AM, et al
    Monitoring orthodontic tooth movement in rats after piezocision by bone scintigraphy.
    Nuklearmedizin. 2022 Jul 27. doi: 10.1055/a-1816-6825.
    >> Share

  64. HOLZGREVE A, Eilsberger F, Einspanner E, Kunz J, et al
    [The Youngsters of the German Society of Nuclear Medicine (Young DGN)].
    Nuklearmedizin. 2022 Jul 11. doi: 10.1055/a-1866-3000.
    >> Share

  65. HESCHELER DA, Stegger L, Schlack K, Bogemann M, et al
    Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement.
    Nuklearmedizin. 2022 Jul 11. doi: 10.1055/a-1809-4570.
    >> Share

    June 2022
  66. ZHANG R, Hohenforst-Schmidt W, Steppert C, Sziklavari Z, et al
    Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naive patients with non-small cell lung cancer.
    Nuklearmedizin. 2022 Jun 29. doi: 10.1055/a-1816-6950.
    >> Share

  67. TULIPAN AJ, Guzman AJ, Haslerud TM, Foldnes K, et al
    Enhancing PSMA-PET/CT with intravenous contrast: Improved tracer clearance in the prostate bed.
    Nuklearmedizin. 2022 Jun 14. doi: 10.1055/a-1821-8112.
    >> Share

  68. KURTH J, Potratz M, Heuschkel M, Krause BJ, et al
    GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals.
    Nuklearmedizin. 2022;61:247-261.
    >> Share

    April 2022
  69. SCHMIDT M, Bartenstein P, Bucerius J, Dietlein M, et al
    Correction: Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine.
    Nuklearmedizin. 2022 Apr 27. doi: 10.1055/a-1824-1280.
    >> Share

  70. FREUDENBERG R, Hesse L, Kotzerke J
    [Evaluation of radionuclide impurities in several radiopharmaceuticals].
    Nuklearmedizin. 2022 Apr 14. doi: 10.1055/a-1759-1815.
    >> Share

  71. WANKE C, Szemerski B, Geworski L
    [Incorporation Monitoring of Staff using I-131 and Lu-177 in a Nuclear Medicine Ward].
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1759-1940.
    >> Share

  72. RINSCHEID A, Janzen T, Alikhani B, Beer AJ, et al
    Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in Germany.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1759-3900.
    >> Share

  73. MULLER PJ, Dietlein M, Kobe C, Heidenreich A, et al
    Oligometastatic disease in biochemical recurrence of prostate cancer: Prevalence on PSMA PET/CT and consecutive metastasis-directed therapy - Experience at a tertiary referral center.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1697-8111.
    >> Share

  74. EILSBERGER F, Girmond C, Boekhoff J, Librizzi D, et al
    [High clinical value of bone scintigraphy as a staging method for breast cancer].
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1780-8378.
    >> Share

  75. USLU H, Orhan Varoglu A, Tatoglu MT, Kilicaslan E, et al
    A Case of Chorea-Acanthocytosis with FDG PET/CT Imaging.
    Nuklearmedizin. 2022 Apr 6. doi: 10.1055/a-1780-8463.
    >> Share

  76. LENGANA T, Lawal I, Janse Van Rensburg C, Mokoala K, et al
    The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/ml.
    Nuklearmedizin. 2022;61:120-129.
    >> Share

  77. SCHMIDT M, Decarolis B, Franzius C, Hero B, et al

    Nuklearmedizin. 2022;61:96-110.
    >> Share

    March 2022
  78. SCHMIDT M, Bartenstein P, Bucerius J, Dietlein M, et al
    Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine.
    Nuklearmedizin. 2022 Mar 17. doi: 10.1055/a-1783-8154.
    >> Share

    February 2022
  79. BOSWIJK E, de Ligt M, Habets MJ, Mingels AMA, et al
    Resveratrol treatment does not reduce arterial inflammation in males at risk of type 2 diabetes: a randomized crossover trial.
    Nuklearmedizin. 2022;61:33-41.
    >> Share

  80. KOUKALOVA R, Vasina J, Stika J, Doubek M, et al
    Aggressive systemic mastocytosis with diffuse bone marrow 18F-FDG uptake.
    Nuklearmedizin. 2022;61:58-61.
    >> Share

    January 2022
  81. PARK SB, Lim CH, Chang WH, Hwang JH, et al
    Correction: Diagnostic Value of Bone SPECT/CT Using 99mTc-Methylene Diphosphonate in Patients with Unspecified Chest Wall Pain.
    Nuklearmedizin. 2022 Jan 21. doi: 10.1055/a-1728-8828.
    >> Share

  82. ROWE SP, Buck A, Bundschuh RA, Lapa C, et al
    [18F]DCFPyL PET/CT for Imaging of Prostate Cancer.
    Nuklearmedizin. 2022 Jan 14. doi: 10.1055/a-1659-0010.
    >> Share

    December 2021
  83. NAM HY, Seo S, Lee MJ, Kim K, et al
    No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjects.
    Nuklearmedizin. 2021;60:434-437.
    >> Share

  84. BERLINER C, Boss K, Pape A, Kribben A, et al
    [Oldies (but Goldies): Peritoneal Scintigraphy in Chronic Peritoneal Dialysis Patients].
    Nuklearmedizin. 2021;60:450-453.
    >> Share

    November 2021
  85. RADZIKOWSKI KC, Rendl G, Beheshti M, Pirich C, et al
    18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.
    Nuklearmedizin. 2021 Nov 29. doi: 10.1055/a-1670-9315.
    >> Share

  86. PARK SB, Lim CH, Chang WH, Hwang JH, et al
    Diagnostic Value of Bone SPECT/CT Using 99mTc-Methylene Diphosphonate in Patients with Unspecified Chest Wall Pain.
    Nuklearmedizin. 2021 Nov 12. doi: 10.1055/a-1549-5910.
    >> Share

    October 2021
  87. MIEDERER M
    Alpha emitting nuclides in nuclear medicine theranostics.
    Nuklearmedizin. 2021 Oct 8. doi: 10.1055/a-1650-9995.
    >> Share

  88. ROGASCH JMM, Penzkofer T
    AI in nuclear medicine - what, why and how?
    Nuklearmedizin. 2021;60:321-324.
    >> Share

    September 2021
  89. STOLZENBACH LF, Locherbach F, Wargenau K, Pose R, et al
    Correction: Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.
    Nuklearmedizin. 2021 Sep 3. doi: 10.1055/a-1626-6669.
    >> Share

  90. FARAG S, IJzerman NS, Houdijk MPM, Reyners AKL, et al
    Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intent.
    Nuklearmedizin. 2021 Sep 3. doi: 10.1055/a-1542-6211.
    >> Share

    August 2021
  91. STOLZENBACH LF, Locherbach F, Wargenau K, Pose R, et al
    Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities.
    Nuklearmedizin. 2021 Aug 20. doi: 10.1055/a-1542-6064.
    >> Share

  92. POETZSCH S, Brenner W, Spreckelmeyer S
    Are radiopharmaceuticals self-sterilizing? Radiation effect of gallium-68 and lutetium-177 on bacillus pumilus and staphylococcus succinus.
    Nuklearmedizin. 2021 Aug 20. doi: 10.1055/a-1547-0628.
    >> Share

  93. YANG X, You Z, Chen Y, Dai T, et al
    Thymic squamous cell carcinoma mimicking lymphoma on 68Ga-FAPI PET/CT.
    Nuklearmedizin. 2021 Aug 17. doi: 10.1055/a-1561-2014.
    >> Share

  94. BECK MT, Rugel G, Reinfelder J, Kuwert T, et al
    Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw.
    Nuklearmedizin. 2021 Aug 11. doi: 10.1055/a-1525-7621.
    >> Share

  95. PATT M, Bengel F, Essler M, Krause BJ, et al
    [Fireside chat " section sign 13 (2b) AMG in nuclear medicine therapy" - a follow-up event of NuklearMedizin 2020 - Digital].
    Nuklearmedizin. 2021;60:262-263.
    >> Share



  96. Nuklearmedizin. 2021;60:305.
    >> Share

  97. MIRZAEI S, Prior JO, Farsad M, Lipp RW, et al
    Ausbildung in Nuklearmedizin und Zukunftsperspektiven.
    Nuklearmedizin. 2021;60:264-265.
    >> Share

  98. SUI S, Hou Y
    Assessing Doxorubicin-Induced Cardiomyopathy by 99mTc-3PRGD2 Scintigraphy Targeting Integrin alphavbeta3 in a Rat Model.
    Nuklearmedizin. 2021;60:289-298.
    >> Share

    July 2021
  99. LAPA C, Nestle U, Albert NL, Baues C, et al
    Value of PET imaging for radiation therapy.
    Nuklearmedizin. 2021 Jul 14. doi: 10.1055/a-1525-7029.
    >> Share

  100. KREPPEL B, Gonzalez-Carmona MA, Feldmann G, Kuppers J, et al
    Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours.
    Nuklearmedizin. 2021 Jul 13. doi: 10.1055/a-1521-8604.
    >> Share

  101. SAHIN O, Kaya B, Aydin Z, Sen AE, et al
    Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parameters.
    Nuklearmedizin. 2021 Jul 9. doi: 10.1055/a-1525-7607.
    >> Share

    June 2021
  102. OBMANN VC, Grosse-Hokamp N, Alberts I, Fulton N, et al
    Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver.
    Nuklearmedizin. 2021 Jun 8. doi: 10.1055/a-1486-3671.
    >> Share

  103. HELLWIG D
    Hope for new developments in the reimbursement of oncological PET/CT in Germany.
    Nuklearmedizin. 2021;60:205-208.
    >> Share

  104. FREUDENBERG LS, Klett R, Fischer M, Boddenberg-Patzold B, et al
    [RSO in clinical practice: Status in Germany 2020].
    Nuklearmedizin. 2021;60:224-232.
    >> Share

    April 2021
  105. BARENFANGER F, Block A, Schmelz D, Hamami-Arlinghaus M, et al
    Individual calculation of perfusion activity based on ventilation efficiency for V/P-SPECT.
    Nuklearmedizin. 2021 Apr 16. doi: 10.1055/a-1429-1832.
    >> Share

  106. TATOGLU MT, Uslu H, Ibisoglu E
    The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis.
    Nuklearmedizin. 2021 Apr 9. doi: 10.1055/a-1429-2237.
    >> Share

  107. FREUDENBERG LS, Essler M, Herrmann K
    [Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey].
    Nuklearmedizin. 2021 Apr 1. doi: 10.1055/a-1446-7641.
    >> Share



  108. Nuklearmedizin. 2021;60:76-77.
    >> Share

  109. PEKTOR S, Lawaczeck L, Tenzer S, Bausbacher N, et al
    Characterization of activation induced [18]F-FDG uptake in Dendritic Cells.
    Nuklearmedizin. 2021;60:90-98.
    >> Share

    February 2021


  110. Nuklearmedizin. 2021;60:59-63.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016